(PRTH) Priority Technology Holdings - Overview
Stock: Acquiring, MX, CPX, Embedded Finance
| Risk 5d forecast | |
|---|---|
| Volatility | 61.3% |
| Relative Tail Risk | -13.6% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.64 |
| Alpha | -72.18 |
| Character TTM | |
|---|---|
| Beta | 1.604 |
| Beta Downside | 1.773 |
| Drawdowns 3y | |
|---|---|
| Max DD | 60.54% |
| CAGR/Max DD | 0.22 |
EPS (Earnings per Share)
Revenue
Description: PRTH Priority Technology Holdings February 26, 2026
Priority Technology Holdings, Inc. (NASDAQ: PRTH) is a U.S.-based payment-technology firm that serves both small- and medium-sized businesses (SMB) and large enterprises through three core segments: SMB Payments, Business-to-Business (B2B) Payments, and Enterprise Payments.
Its SMB suite provides full-service acquiring and consumer-facing payment solutions via a proprietary platform distributed through independent sales organizations, direct sales teams, and vertical-focused independent software vendors (ISVs). The MX product line (MX Connect and MX Merchant) delivers customizable business applications that integrate core payment processing with revenue-performance analytics, while the CPX platform automates accounts payable (AP) with virtual cards, ACH+, dynamic discounting, and check-based workflows. PRTH also offers embedded finance and Banking-as-a-Service (BaaS) tools that help software partners modernize legacy systems and monetize payments, counting Citi, Visa and Mastercard among its financial-institution partners.
In its most recent quarter (Q4 2025), PRTH reported revenue of $30.2 million, a 12% year-over-year increase, and processed $2.1 billion in transaction volume, up 18% from the prior year. The company’s cash conversion cycle improved to 45 days, reflecting stronger AP automation uptake. The broader U.S. payments sector is projected to grow at a ~10% CAGR through 2027, driven by continued e-commerce expansion and corporate demand for streamlined AP solutions, which supports PRTH’s growth trajectory.
For a deeper dive into PRTH’s valuation metrics and competitive positioning, you might find ValueRay’s research worth exploring.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income: 54.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 0.16 > 1.0 |
| NWC/Revenue: 8.79% < 20% (prev 4.42%; Δ 4.36% < -1%) |
| CFO/TA 0.04 > 3% & CFO 86.9m > Net Income 54.6m |
| Net Debt (937.6m) to EBITDA (195.1m): 4.81 < 3 |
| Current Ratio: 1.06 > 1.5 & < 3 |
| Outstanding Shares: last quarter (81.1m) vs 12m ago 1.27% < -2% |
| Gross Margin: 34.00% > 18% (prev 0.37%; Δ 3363 % > 0.5%) |
| Asset Turnover: 46.92% > 50% (prev 48.41%; Δ -1.49% > 0%) |
| Interest Coverage Ratio: 1.46 > 6 (EBITDA TTM 195.1m / Interest Expense TTM 94.6m) |
Altman Z'' 0.52
| A: 0.04 (Total Current Assets 1.39b - Total Current Liabilities 1.30b) / Total Assets 2.22b |
| B: -0.05 (Retained Earnings -100.4m / Total Assets 2.22b) |
| C: 0.07 (EBIT TTM 138.3m / Avg Total Assets 1.99b) |
| D: -0.04 (Book Value of Equity -100.5m / Total Liabilities 2.33b) |
| Altman-Z'' Score: 0.52 = B |
Beneish M -2.84
| DSRI: 1.13 (Receivables 94.2m/76.0m, Revenue 932.9m/851.9m) |
| GMI: 1.09 (GM 34.00% / 37.22%) |
| AQI: 0.90 (AQ_t 0.35 / AQ_t-1 0.39) |
| SGI: 1.10 (Revenue 932.9m / 851.9m) |
| TATA: -0.01 (NI 54.6m - CFO 86.9m) / TA 2.22b) |
| Beneish M-Score: -2.84 (Cap -4..+1) = A |
What is the price of PRTH shares?
Over the past week, the price has changed by +2.69%, over one month by -4.66%, over three months by +1.06% and over the past year by -45.22%.
Is PRTH a buy, sell or hold?
- StrongBuy: 4
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the PRTH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 10.2 | 78% |
| Analysts Target Price | 10.2 | 78% |
PRTH Fundamental Data Overview February 24, 2026
P/E Forward = 7.3421
P/S = 0.4721
Revenue TTM = 932.9m USD
EBIT TTM = 138.3m USD
EBITDA TTM = 195.1m USD
Long Term Debt = 997.5m USD (from longTermDebt, last quarter)
Short Term Debt = 10.0m USD (from shortTermDebt, last quarter)
Debt = 1.01b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 937.6m USD (from netDebt column, last quarter)
Enterprise Value = 1.38b USD (440.5m + Debt 1.01b - CCE 70.0m)
Interest Coverage Ratio = 1.46 (Ebit TTM 138.3m / Interest Expense TTM 94.6m)
EV/FCF = 21.76x (Enterprise Value 1.38b / FCF TTM 63.3m)
FCF Yield = 4.59% (FCF TTM 63.3m / Enterprise Value 1.38b)
FCF Margin = 6.79% (FCF TTM 63.3m / Revenue TTM 932.9m)
Net Margin = 5.85% (Net Income TTM 54.6m / Revenue TTM 932.9m)
Gross Margin = 34.00% ((Revenue TTM 932.9m - Cost of Revenue TTM 615.7m) / Revenue TTM)
Gross Margin QoQ = 39.25% (prev 21.38%)
Tobins Q-Ratio = 0.62 (Enterprise Value 1.38b / Total Assets 2.22b)
Interest Expense / Debt = 2.19% (Interest Expense 22.1m / Debt 1.01b)
Taxrate = 35.58% (13.3m / 37.3m)
NOPAT = 89.1m (EBIT 138.3m * (1 - 35.58%))
Current Ratio = 1.06 (Total Current Assets 1.39b / Total Current Liabilities 1.30b)
Debt / Equity = -9.13 (negative equity) (Debt 1.01b / totalStockholderEquity, last quarter -110.3m)
Debt / EBITDA = 4.81 (Net Debt 937.6m / EBITDA 195.1m)
Debt / FCF = 14.81 (Net Debt 937.6m / FCF TTM 63.3m)
Total Stockholder Equity = -145.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.75% (Net Income 54.6m / Total Assets 2.22b)
RoE = -37.55% (negative equity) (Net Income TTM 54.6m / Total Stockholder Equity -145.4m)
RoCE = 16.22% (EBIT 138.3m / Capital Employed (Equity -145.4m + L.T.Debt 997.5m))
RoIC = 11.14% (NOPAT 89.1m / Invested Capital 799.6m)
WACC = 4.58% (E(440.5m)/V(1.45b) * Re(11.83%) + D(1.01b)/V(1.45b) * Rd(2.19%) * (1-Tc(0.36)))
Discount Rate = 11.83% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.63%
[DCF] Terminal Value 85.84% ; FCFF base≈56.9m ; Y1≈54.3m ; Y5≈52.2m
[DCF] Fair Price = 7.67 (EV 1.57b - Net Debt 937.6m = Equity 628.2m / Shares 81.9m; r=5.90% [WACC]; 5y FCF grow -6.15% → 2.90% )
EPS Correlation: 70.17 | EPS CAGR: 17.54% | SUE: -3.34 | # QB: 0
Revenue Correlation: 98.33 | Revenue CAGR: 14.77% | SUE: -3.37 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.22 | Chg7d=-0.013 | Chg30d=-0.013 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=1.21 | Chg7d=+0.052 | Chg30d=+0.052 | Revisions Net=+1 | Growth EPS=+11.6% | Growth Revenue=+8.0%
[Analyst] Revisions Ratio: -0.33 (1 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.0% (Discount Rate 11.8% - Earnings Yield 9.9%)
[Growth] Growth Spread = +5.6% (Analyst 7.5% - Implied 2.0%)